Annual CFI
-$69.19 M
+$105.12 M+60.31%
31 December 2023
Summary:
Amneal Pharmaceuticals annual cash flow from investing activities is currently -$69.19 million, with the most recent change of +$105.12 million (+60.31%) on 31 December 2023. During the last 3 years, it has risen by +$248.36 million (+78.21%). AMRX annual CFI is now -253.37% below its all-time high of -$19.58 million, reached on 31 December 2019.AMRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$20.71 M
-$14.25 M-220.37%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly cash flow from investing activities is currently -$20.71 million, with the most recent change of -$14.25 million (-220.37%) on 30 September 2024. Over the past year, it has dropped by -$7.24 million (-53.70%). AMRX quarterly CFI is now -169.08% below its all-time high of $29.98 million, reached on 30 September 2019.AMRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$78.63 M
-$7.24 M-10.14%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM cash flow from investing activities is currently -$78.63 million, with the most recent change of -$7.24 million (-10.14%) on 30 September 2024. Over the past year, it has dropped by -$29.67 million (-60.59%). AMRX TTM CFI is now -728.37% below its all-time high of -$9.49 million, reached on 30 September 2019.AMRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.3% | -53.7% | -60.6% |
| 3 y3 years | +78.2% | -78.0% | +43.4% |
| 5 y5 years | +82.5% | -169.1% | -728.4% |
AMRX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +78.2% | -220.4% | +78.7% | -60.6% | +71.8% |
| 5 y | 5 years | -253.4% | +82.5% | -169.1% | +92.1% | -728.4% | +75.2% |
| alltime | all time | -253.4% | +82.5% | -169.1% | +93.9% | -728.4% | +80.4% |
Amneal Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.71 M(+220.4%) | -$78.63 M(+10.1%) |
| June 2024 | - | -$6.46 M(-67.3%) | -$71.39 M(-7.5%) |
| Mar 2024 | - | -$19.76 M(-37.6%) | -$77.21 M(+11.6%) |
| Dec 2023 | -$69.19 M(-60.3%) | -$31.69 M(+135.2%) | -$69.19 M(+41.3%) |
| Sept 2023 | - | -$13.48 M(+9.7%) | -$48.96 M(-42.3%) |
| June 2023 | - | -$12.28 M(+4.7%) | -$84.82 M(-4.3%) |
| Mar 2023 | - | -$11.74 M(+2.4%) | -$88.65 M(-49.1%) |
| Dec 2022 | -$174.31 M(-10.2%) | -$11.47 M(-76.8%) | -$174.31 M(-30.2%) |
| Sept 2022 | - | -$49.33 M(+206.1%) | -$249.81 M(+17.8%) |
| June 2022 | - | -$16.12 M(-83.5%) | -$212.11 M(-23.9%) |
| Mar 2022 | - | -$97.39 M(+12.0%) | -$278.88 M(+43.6%) |
| Dec 2021 | -$194.18 M | -$86.97 M(+647.6%) | -$194.18 M(+39.7%) |
| Sept 2021 | - | -$11.63 M(-86.0%) | -$139.01 M(-2.2%) |
| June 2021 | - | -$82.89 M(+553.0%) | -$142.16 M(+108.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.69 M(-60.1%) | -$68.20 M(-78.5%) |
| Dec 2020 | -$317.55 M(+1521.8%) | -$31.80 M(+115.1%) | -$317.55 M(+9.3%) |
| Sept 2020 | - | -$14.78 M(+65.6%) | -$290.52 M(+18.2%) |
| June 2020 | - | -$8.93 M(-96.6%) | -$245.75 M(-5.5%) |
| Mar 2020 | - | -$262.04 M(+5397.0%) | -$260.16 M(+1228.7%) |
| Dec 2019 | -$19.58 M(-95.1%) | -$4.77 M(-115.9%) | -$19.58 M(+106.3%) |
| Sept 2019 | - | $29.98 M(-228.5%) | -$9.49 M(-88.2%) |
| June 2019 | - | -$23.33 M(+8.7%) | -$80.25 M(-79.9%) |
| Mar 2019 | - | -$21.47 M(-503.4%) | -$398.35 M(+0.5%) |
| Dec 2018 | -$396.38 M(+302.2%) | $5.32 M(-113.0%) | -$396.38 M(-1.3%) |
| Sept 2018 | - | -$40.77 M(-88.1%) | -$401.70 M(+11.3%) |
| June 2018 | - | -$341.43 M(+1651.0%) | -$360.92 M(+1751.0%) |
| Mar 2018 | - | -$19.50 M | -$19.50 M |
| Dec 2017 | -$98.55 M(-20.9%) | - | - |
| Dec 2016 | -$124.61 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual CFI year-on-year change?
- What is Amneal Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly CFI year-on-year change?
- What is Amneal Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM CFI year-on-year change?
What is Amneal Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AMRX is -$69.19 M
What is the all time high annual CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual cash flow from investing activities is -$19.58 M
What is Amneal Pharmaceuticals annual CFI year-on-year change?
Over the past year, AMRX annual cash flow from investing activities has changed by +$105.12 M (+60.31%)
What is Amneal Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AMRX is -$20.71 M
What is the all time high quarterly CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly cash flow from investing activities is $29.98 M
What is Amneal Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AMRX quarterly cash flow from investing activities has changed by -$7.24 M (-53.70%)
What is Amneal Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AMRX is -$78.63 M
What is the all time high TTM CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM cash flow from investing activities is -$9.49 M
What is Amneal Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AMRX TTM cash flow from investing activities has changed by -$29.67 M (-60.59%)